Intracanal Corticosteroid Solution for Post-Endodontic Pain Relief in Irreversible Pulpitis and Apical Periodontitis
Dexamethasone
+ Placebo
Neurologic Manifestations+4
+ Pain
+ Pain, Postoperative
Treatment Study
Summary
Study start date: March 1, 2025
Actual date on which the first participant was enrolled.This study is focused on understanding if intentionally pushing a corticosteroid solution, specifically dexamethasone, beyond the root canal into the surrounding tissue can help reduce pain after root canal treatment. The study targets patients who have symptomatic irreversible pulpitis and symptomatic apical periodontitis, which are conditions associated with significant dental pain and inflammation. By exploring this method, the research aims to find better ways to manage pain without relying solely on traditional pain relief methods, potentially leading to improved recovery experiences for patients undergoing root canal procedures. Participants in this study will receive a root canal treatment where either a dexamethasone solution or a placebo is used. The method involves carefully allowing the solution to extend beyond the root canal into the tissues around the root. The main focus is to observe any reduction in pain levels following the procedure, comparing the effects of the corticosteroid to those of the placebo. This approach involves some degree of risk as it intentionally breaches the canal barrier, but it is closely monitored to ensure patient safety while investigating the potential benefits.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.80 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 70 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives